Sort
261,768 grants matching “gene therapy”
Structure and Function of Vif and APOBEC3 (A3) Proteins
$850,901Vinay K. Pathak · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Genome-Wide Association Study in African-Americans with Rheumatoid Arthritis
$850,893S Louis Bridges · University Of Alabama At Birmingham · R01 · FY2012 · AR
Autism genetics: homozygosity mapping and functional validation
$850,815Christopher A Walsh · Boston Children'S Hospital · R01 · FY2012 · MH
Studying and regulating trained immunity in mouse transplant models
$850,787Abraham Teunissen · Icahn School Of Medicine At Mount Sinai · P01 · FY2023 · AI
Genome-Wide Discovery and Translational Research for Neural Repair
$850,774Stephen M Strittmatter · Yale University · R35 · FY2017 · NS
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
$850,753Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2017 · CA
Translational Research for Retinal Degeneration Therapies
$850,749Gustavo David Aguirre · University Of Pennsylvania · R01 · FY2009 · EY
Multimodality Imaging of GI Cancers for Diagnosis and Directed Therapy
$850,747Christopher H Contag · Stanford University · U54 · FY2012 · CA
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$850,736Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Pharmacogenomics of ART adherence and effectiveness in the ALIVE Cohort
$850,704Brion S Maher · Johns Hopkins University · R01 · FY2022 · DA
Identifying driver mutations and tumor dependencies by comparative oncogenomics.
$850,689Scott W Lowe · Cold Spring Harbor Laboratory · U01 · FY2013 · CA
Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine
$850,670Afamefuna Okoye · Oregon Health & Science University · R01 · FY2020 · AI
CAMPO Clinical Trials Program
$850,637Joel Palefsky · University Of California, San Francisco · U54 · FY2021 · CA
Abiraterone Acetate in Childen with Classic 21-Hydroxylase Deficiency
$850,622Perrin C White · Ut Southwestern Medical Center · U01 · FY2018 · HD
Abiraterone Acetate in Childen with Classic 21-Hydroxylase Deficiency
$850,621Perrin C White · Ut Southwestern Medical Center · U01 · FY2019 · HD
Regulation of mitochondrial activity and metastasis by dihydrouridine-modified tRNAs in renal cell carcinoma
$850,611Joshua T Mendell · Ut Southwestern Medical Center · U01 · FY2025 · CA
Development and non-clinical GLP testing of a new anti-arteriosclerosis gene therapy delivered by engineered adeno-associated viral vectors.
$850,531Maurizio Chiriva-Internati · Kiromic, Inc. · R42 · FY2018 · HL
In-depth characterization of myeloid cells in human milk from HIV- and HIV+ donors as potential vehicles of and defenders against vertical transmission of HIV: essential data for targeted therapeutics
$850,491Rebecca Powell · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
Preclinical Mouse Models of Thyroid Cancer
$850,417Sheue-Yann Cheng · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Blockade of the SDF-1/CXCR4 axis as a novel strategy for mitigating radiation-ind
$850,335Hui-Kuo Shu · Emory University · RC1 · FY2010 · AI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection
$850,330Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2016 · AI
Basic Research Support for the CCR
$850,265Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Project #3 In vivo microneurography recordings of sensory afferents
$850,240Hã
kan Olausson · University Of Pennsylvania · U19 · FY2023 · NS
Targeted interventions to reduce or eliminate the SIV reservoir in a novel model of elite control
$850,199James A Hoxie · University Of Pennsylvania · R01 · FY2020 · AI
Process Development and Preclinical Advancement of a Novel Nanoparticle Formulation for Immune Activation
$850,188Richard Johnson · Saros Therapeutics Inc · R44 · FY2024 · CA